$0.59
1.06% day before yesterday
NYSE, Dec 27, 10:18 pm CET
ISIN
US81727U1051
Symbol
SENS

Senseonics Stock price

$0.59
+0.28 92.27% 1M
+0.18 45.00% 6M
+0.02 3.88% YTD
+0.02 3.24% 1Y
-2.24 79.07% 3Y
-0.31 34.64% 5Y
-2.66 81.78% 10Y
NYSE, Closing price Fri, Dec 27 2024
+0.01 1.06%
ISIN
US81727U1051
Symbol
SENS
Sector

Key metrics

Market capitalization $352.55m
Enterprise Value $375.55m
P/E (TTM) P/E ratio negative
EV/FCF (TTM) EV/FCF negative
EV/Sales (TTM) EV/Sales 16.91
P/S ratio (TTM) P/S ratio 15.87
P/B ratio (TTM) P/B ratio negative
Revenue growth (TTM) Revenue growth 11.41%
Revenue (TTM) Revenue $22.21m
EBIT (operating result TTM) EBIT $-77.58m
Free Cash Flow (TTM) Free Cash Flow $-63.42m
Cash position $74.80m
EPS (TTM) EPS $-0.13
P/E forward negative
P/S forward 16.04
EV/Sales forward 17.09
Short interest 7.14%
Show more

Is Senseonics a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 6,886 stocks worldwide.

Senseonics Stock Analysis

Unlock Scores for Free

Analyst Opinions

5 Analysts have issued a Senseonics forecast:

2x Buy
40%
1x Hold
20%
2x Sell
40%

Analyst Opinions

5 Analysts have issued a Senseonics forecast:

Buy
40%
Hold
20%
Sell
40%

Financial data from Senseonics

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Sep '24
+/-
%
22 22
11% 11%
100%
- Direct Costs 25 25
42% 42%
110%
-2.33 -2.33
189% 189%
-10%
- Selling and Administrative Expenses 31 31
6% 6%
141%
- Research and Development Expense 43 43
14% 14%
191%
-76 -76
0% 0%
-343%
- Depreciation and Amortization 1.35 1.35
53% 53%
6%
EBIT (Operating Income) EBIT -78 -78
0% 0%
-349%
Net Profit -80 -80
154% 154%
-362%

In millions USD.

Don't miss a Thing! We will send you all news about Senseonics directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Senseonics Stock News

Neutral
Seeking Alpha
about 2 months ago
Senseonics Holdings, Inc. (NYSE:SENS ) Q3 2024 Earnings Conference Call November 7, 2024 4:30 PM ET Company Participants Jeremy Feffer - LifeSci Advisors Tim Goodnow - President and Chief Executive Officer Rick Sullivan - Chief Financial Officer Brian Hansen - President of CGM at Ascensia Diabetes Care Conference Call Participants Brian Langan - Morgan Stanley Vernon Bernardino - H.C. Wainwrigh...
Neutral
GlobeNewsWire
2 months ago
Event featuring David T. Ahn, MD from Hoag Medical Group and Jeff Ciaramita, MD from Mercy health system, along with management Event featuring David T. Ahn, MD from Hoag Medical Group and Jeff Ciaramita, MD from Mercy health system, along with management
Neutral
PRNewsWire
3 months ago
Senseonics' Eversense 365 is approved in the US as an integrated continuous glucose monitoring (iCGM) system for people with Type 1 and Type 2 diabetes aged 18 and older Commercial launch by Ascensia Diabetes Care underway with a new campaign to highlight the unique benefits of having just one CGM for one full year GERMANTOWN, Md. and ST. LOUIS , Oct. 10, 2024 /PRNewswire/ -- Senseonics Holding...
More Senseonics News

Company Profile

Senseonics Holdings, Inc. engages in the design, development, and commercialization of an implantable continuous glucose monitoring system for people with diabetes. Its primary product is the brand Eversense, a glucose monitoring device which includes sensors, smart transmitters, and mobile applications. The company was founded on June 26, 2014 and is headquartered in Germantown, MD.

Head office United States
CEO Timothy Goodnow
Employees 132
Founded 2014
Website www.senseonics.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today